Antagonistic anti-hFas ligand human antibodies and fragments thereof

Details for Australian Patent Application No. 2003219954 (hide)

Owner Eli Lilly and Company

Inventors Lancaster, Joanne Sloan

Agent Spruson & Ferguson

Pub. Number AU-B-2003219954

PCT Number PCT/US03/06155

PCT Pub. Number WO2003/079750

Priority 60/367,054 21.03.02 US; 60/409,768 10.09.02 US

Filing date 12 March 2003

Wipo publication date 8 October 2003

Acceptance publication date 9 November 2006

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/367,054 21.03.02 US; 60/409,768 10.09.02 US

13 November 2003 Application Open to Public Inspection

  Published as AU-B-2003219954

9 November 2006 Application Accepted

  Published as AU-B-2003219954

8 March 2007 Standard Patent Sealed

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003219955-ISOQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES AS EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS

2003219953-Cathepsin cysteine protease inhibitors